News
Cardinal Health (NYSE: CAH) today announced that The Specialty Alliance, its multi-specialty management services organization ...
The healthcare conglomerate handily beat on the bottom line in its latest reported quarter, but that's not what the market was paying attention to.
Cardinal Health, Inc. is rated a Buy with a $239 fair value, driven by specialty growth in autoimmune, urology & oncology.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results